Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Camacho

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infection|January 4, 2023
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general populationJorge Camacho, Joao Zulaica, Estela Giménez, et al.
AIDS (London, England)|October 18, 2005
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or GAna Barroso Abecasis, Koen Deforche, Joke Snoeck, et al.
Retrovirology|December 22, 2016
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision supportMatthias Döring, Pedro Borrego, Joachim Büch, et al.
Journal of Medical Virology|July 21, 2021
Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency departmentSilvia Carbonell-Sahuquillo, María I Lázaro-Carreño, Jorge Camacho, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2012
Mutations selected in HIV-2-infected patients failing a regimen including atazanavirJoana Cavaco-Silva, Maria João Aleixo, Kristel Van Laethem, et al.
Physics in Medicine and Biology|February 6, 2025
Dual photoacoustic/ultrasound technologies for preclinical research: current status and future trendsMailyn Pérez-Liva, María Alonso de Leciñana, María Gutiérrez-Fernández, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2012
The demise of multidrug-resistant HIV-1: the national time trend in PortugalJurgen Vercauteren, Kristof Theys, Ana Patricia Carvalho, et al.
Plos One|April 1, 2014
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimenJoana Cavaco-Silva, Ana Abecasis, Ana Cláudia Miranda, et al.
Journal of Medical Virology|November 5, 2022
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variantJorge Camacho, Estela Giménez, Eliseo Albert, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2026
Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain-DDR StudyAna Alberola, Adolfo de Salazar, Ana Fuentes, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infection|January 4, 2023
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general populationJorge Camacho, Joao Zulaica, Estela Giménez, et al.
AIDS (London, England)|October 18, 2005
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or GAna Barroso Abecasis, Koen Deforche, Joke Snoeck, et al.
Retrovirology|December 22, 2016
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision supportMatthias Döring, Pedro Borrego, Joachim Büch, et al.
Journal of Medical Virology|July 21, 2021
Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency departmentSilvia Carbonell-Sahuquillo, María I Lázaro-Carreño, Jorge Camacho, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2012
Mutations selected in HIV-2-infected patients failing a regimen including atazanavirJoana Cavaco-Silva, Maria João Aleixo, Kristel Van Laethem, et al.
Physics in Medicine and Biology|February 6, 2025
Dual photoacoustic/ultrasound technologies for preclinical research: current status and future trendsMailyn Pérez-Liva, María Alonso de Leciñana, María Gutiérrez-Fernández, et al.
The Journal of Antimicrobial Chemotherapy|December 12, 2012
The demise of multidrug-resistant HIV-1: the national time trend in PortugalJurgen Vercauteren, Kristof Theys, Ana Patricia Carvalho, et al.
Plos One|April 1, 2014
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimenJoana Cavaco-Silva, Ana Abecasis, Ana Cláudia Miranda, et al.
Journal of Medical Virology|November 5, 2022
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variantJorge Camacho, Estela Giménez, Eliseo Albert, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2026
Nationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain-DDR StudyAna Alberola, Adolfo de Salazar, Ana Fuentes, et al.
Pageof 5